Urinary Cytokines in Patients With Overactive Bladder (OAB)

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

August 31, 2009

Conditions
Overactive BladderUrinary Tract Infection
Trial Locations (1)

33331

Cleveland Clinic Florida, Weston

All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

The Cleveland Clinic

OTHER

NCT00868621 - Urinary Cytokines in Patients With Overactive Bladder (OAB) | Biotech Hunter | Biotech Hunter